2016 annual financial data
CytomX Therapeutics 2016 Operating margin
Direct answer
Operating margin was -396.1%.
Operating income was -59,586,000 USD and net income was -58,900,000 USD.
Operating cash flow was -2,032,000 USD.
Get free CytomX Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 15,043,000 USD
- Operating income
- -59,586,000 USD
- Net income
- -58,900,000 USD
- Operating cash flow
- -2,032,000 USD